FIELD: medicine. SUBSTANCE: method involves administering alpha-fetoprotein in parenteral mode or as external applications at a single dose of 500-5000 IU/kg once or twice a day during 4-6 weeks. Before being applied, the preparation is diluted with 5-200 ml of physiological salt solution. EFFECT: enhanced effectiveness of treatment; excluded adverse side effects. 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICINAL COMPOSITION FOR TREATMENT OF PATIENTS WITH MALIGNANT NEOPLASMS | 1996 |
|
RU2112547C1 |
| METHOD OF TREATING CONDITIONS CHARACTERIZING BY AUTOIMMUNE AGGRESSION | 1995 |
|
RU2137477C1 |
| METHOD OF TREATMENT OF PATIENTS WITH PRIMARY LIVER CANCER AND SET FOR TREATMENT OF PATIENTS WITH PRIMARY LIVER CANCER | 1998 |
|
RU2134589C1 |
| METHOD OF TREATING PATIENTS WITH SKIN CANCER WITH NEOPLASTIC PROCESSES INVOLVING SKIN TISSUE, SUCH AS MELANOMA, BASAL CELL AND SQUAMOUS CELL CARCINOMA (VERSIONS) | 2014 |
|
RU2577135C2 |
| METHOD FOR TREATING LOCALLY GENERALIZED CANCER OF THE MAMMARY GLAND WITH TUMOR-INDUCED SKIN ULCERS | 2001 |
|
RU2176922C1 |
| METHOD TO TREAT MALIGNANT NEOPLASMS AND COMBINED PREPARATION OF ANTITUMOR ACTION TO PERFORM THE METHOD | 2000 |
|
RU2179452C1 |
| METHOD FOR PROPHYLACTIC TREATMENT IN CASE OFNEOPLASTIC PROCESSES INVOLVING SKIN TISSUE, SUCH AS MELANOMA, BASAL CELL AND SQUAMOUS CELL CARCINOMA | 2015 |
|
RU2619208C2 |
| CYTOKINE-CONTAINING COMPOSITION FOR TREATING VIRAL DISEASES | 2009 |
|
RU2447897C2 |
| MEDICATION COMPOSITION AND METHOD OF ITS OBTAINING FOR TREATMENT OF CHRONIC VIRAL HEPATITIS B OR C AND AIDS | 2010 |
|
RU2440133C2 |
| METHOD OF ANTITUMORAL THERAPY IN CASE OF PRIMARY HEPATIC CARCINOMA | 1993 |
|
RU2026679C1 |
